Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic β -cell function and reduction of insulin resistance
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beneficial effects of sodium-glucose cotransporter 2 inhibitors for preservation of pancreatic β
-cell function and reduction of insulin resistance
Authors
Keywords
-
Journal
Journal of Diabetes
Volume 9, Issue 3, Pages 219-225
Publisher
Wiley
Online
2016-10-18
DOI
10.1111/1753-0407.12494
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice
- (2016) Seizo Okauchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice
- (2016) Atsushi Obata et al. ENDOCRINOLOGY
- Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment
- (2016) Meric Erikci Ertunc et al. JOURNAL OF LIPID RESEARCH
- Evolving function and potential of pancreatic alpha cells
- (2015) Violeta Stanojevic et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Short-term selective alleviation of glucotoxicity and lipotoxicity ameliorates the suppressed expression of key β-cell factors under diabetic conditions
- (2015) Naoki Shimo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor
- (2015) Pablo Lapuerta et al. Diabetes & Vascular Disease Research
- Role of Pancreatic Transcription Factors in Maintenance of Mature β-Cell Function
- (2015) Hideaki Kaneto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preserving Mafa Expression in Diabetic Islet β-Cells Improves Glycemic Controlin Vivo
- (2015) Taka-aki Matsuoka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes
- (2015) Tomohiko Kimura et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Combination of DPP-4 inhibitor and PPARγ agonist exerts protective effects on pancreatic β-cells in diabetic db/db mice through the augmentation of IRS-2 expression
- (2015) Hidenori Hirukawa et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
- (2015) Caroline Bonner et al. NATURE MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Appropriate therapy for type 2 diabetes mellitus in view of pancreatic β-cell glucose toxicity: “the earlier, the better”
- (2015) Hideaki Kaneto et al. Journal of Diabetes
- β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
- (2014) Philippe A. Halban et al. DIABETES CARE
- SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats
- (2014) Masanori Yokono et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
- (2014) Aurora Merovci et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
- (2014) Ele Ferrannini et al. JOURNAL OF CLINICAL INVESTIGATION
- Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models
- (2014) M Suzuki et al. Nutrition & Diabetes
- Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes
- (2013) Despoina Vasilakou et al. ANNALS OF INTERNAL MEDICINE
- Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
- (2013) J. Bolinder et al. DIABETES OBESITY & METABOLISM
- Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes
- (2012) J. Rosenstock et al. DIABETES CARE
- Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes
- (2012) S. Hamamoto et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise
- (2012) K. Stenlöf et al. DIABETES OBESITY & METABOLISM
- Alpha cells come of age
- (2012) Joel F. Habener et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
- (2012) Christine Clar et al. BMJ Open
- The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes
- (2011) M. Shimoda et al. DIABETOLOGIA
- Effect of alogliptin, pioglitazone and glargine on pancreatic β-cells in diabetic db/db mice
- (2010) Satoshi Kawashima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation of MafA Expression in Pancreatic -Cells in db/db Mice With Diabetes
- (2010) T.-a. Matsuoka et al. DIABETES
- The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats
- (2010) F. R. Macdonald et al. DIABETES OBESITY & METABOLISM
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
- (2010) Clifford J Bailey et al. LANCET
- SGLT2 inhibition — a novel strategy for diabetes treatment
- (2010) Edward C. Chao et al. NATURE REVIEWS DRUG DISCOVERY
- Insulin modulation of glucagon secretion: The role of insulin and other factors in the regulation of glucagon secretion
- (2010) Dan Kawamori et al. Islets
- Molecular mechanism by which pioglitazone preserves pancreatic β-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARγ agonist
- (2009) Yukiko Kanda et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
- (2008) J. F. List et al. DIABETES CARE
- Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
- (2008) Vincent Poitout et al. ENDOCRINE REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More